top of page

Telefone: +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Brecita 50mg Tablet

Brecita 50mg Tablet

Manufacturer/Marketed By : NATCO PHARMA LTD

$2.50 $2.01

Brecita 50mg Tablet is an antiepileptic medication that belongs to a class of drugs known as synaptic vesicles 2 A (SV2A) protein ligands containing the active ingredient Brivaracetam. It is...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

BRIVARACETAM

Active Pharmaceutical Ingredient

Brecita 50mg Tablet

SKU BRECITA-50MG-TABLET
Preço original

US$ 2,50

Preço promocional

US$ 2,01

Brecita 50mg Tablet is an antiepileptic medication that belongs to a class of drugs known as synaptic vesicles 2 A (SV2A) protein ligands containing the active ingredient Brivaracetam. It is used to treat partial-onset seizures in patients with epilepsy. Partial-onset seizures, also known as focal seizures, are a type of epileptic seizure that begins in a specific area or focus within one hemisphere (side) of the brain. These seizures are caused by their localized onset, meaning they originate in a specific region of the brain rather than affecting the entire brain simultaneously. This drug is contraindicated in individuals with known hypersensitivity or allergy to Brecita 50mg Tablet, other similar chemical compounds like levetiracetam or piracetam, or any of the other ingredients. You should not take this medication.  If you have liver problems, it's important to inform your doctor before taking this medicine. Depending on the severity of your liver condition, your doctor may need to adjust your dosage or closely monitor your liver function during treatment. Children who are under 2 years of age should not take this drug. Individuals taking anti-epileptic medicines should be aware of the possibility of experiencing thoughts of harming or killing themselves. While this is a rare side effect, being careful is essential. You should contact your physician immediately if you ever have thoughts of harming or killing yourself while taking this drug. This is important for your safety and well-being. Brecita 50mg Tablet is not recommended during pregnancy because its effects on pregnancy and the unborn baby are not well-known. Pregnant women should consult their doctor for alternative treatments. Breastfeeding is not advised in patients taking this drug because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.

Active Pharmaceutical Ingredient

BRIVARACETAM

Usos

• Treatment of epilepsy

Benefícios

Brecita 50mg Tablet works by selectively binding to synaptic vesicle protein 2A (SV2A) in the brain. This protein is involved in the release of neurotransmitters, including gamma-aminobutyric acid (GABA) and glutamate, which play a major role in regulating brain activity. By binding to SV2A, this drug helps stabilize the release of these neurotransmitters, reducing excessive electrical activity in the brain and preventing seizures.

Efeitos colaterais

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Efeitos colaterais mais comuns

• Flu
• Feeling very tired (Fatigue)
• Dizziness
• Vertigo
• Feeling sick
• Constipation
• Depression
• Anxiety
• Not being able to sleep (Insomnia)
• Irritability
• Infections of the nose and throat
• Cough
• Decreased appetite

Efeitos colaterais comuns

• Depression
• Anxiety

Como usar

Take the Brecita 50mg Tablet as your physician advises. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.

Conselhos de segurança

• Breast Feeding: Breastfeeding is not recommended in patients taking Brecita 50mg Tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
• Alcohol: It is unsafe to consume alcohol while taking Brecita 50mg Tablet. It may reduce the drug's effectiveness and may lead to increased side effects.
• Liver: Brecita 50mg Tablet should be used with caution in severe liver disease patients. A dose adjustment is required based on the condition. Inform your physician if you have any liver problems before starting the treatment.
• Lungs: It is unknown whether Brecita 50mg Tablet can be used in patients with lung diseases. Consult your doctor for more advice.
• Driving: Brecita 50mg Tablet may cause drowsiness, dizziness, or tiredness, particularly at the beginning of treatment or after a dose increase. Therefore, individuals should avoid activities that require alertness, such as driving, cycling, or operating machinery.
• Pregnancy: Brecita 50mg Tablet is not recommended during pregnancy because its effects on pregnancy and the unborn baby are not well-known. Pregnant women should consult their doctor for alternative treatments.

Isenção de responsabilidade

A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.

Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.

Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.

Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.

bottom of page